29 results
8-K
EX-99.1
OSA
ProSomnus, Inc.
16 May 24
ProSomnus Announces Strong First Quarter 2024 Revenue Growth
8:00am
preferred and easy to use, ProSomnus devices have demonstrated excellent efficacy, safety, adherence, and overall outcomes in a growing body of clinical
8-K
EX-10.2
OSA
ProSomnus, Inc.
8 May 24
Entry into a Material Definitive Agreement
9:25am
of any Hazardous Material, or to the extent relating to exposure to Hazardous Materials, the protection of human health or safety.
“Environmental … Canada, Public Safety Canada, or His Majesty’s Treasury of the United Kingdom.
“Secured Obligations” means the Loan Document Obligations.
“Secured
8-K
EX-99.1
OSA
ProSomnus, Inc.
26 Mar 24
ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results
4:22pm
, safety, adherence, and overall outcomes in a growing body of clinical investigations. ProSomnus precision intraoral devices are FDA-cleared
424B3
gd7omebabzwv3
15 Nov 23
Prospectus supplement
4:37pm
8-K
EX-99.1
3i9gt302gal
9 Nov 23
ProSomnus, the Leading Non-CPAP Obstructive Sleep Apnea Therapy, Reports Record Third Quarter 2023 Financial Results
4:35pm
424B3
h8mc2xcse4qvv
9 Aug 23
Prospectus supplement
6:01am
8-K
EX-99.1
f1u6jx 80m4zh7401r
3 Aug 23
ProSomnus Reports Record Second Quarter 2023 Top-Line Financial Results
8:09am
8-K
EX-99.1
2czuuu9tgpa
6 Jul 23
ProSomnus Announces Second Quarter 2023 Investor Call and Business Update
8:30am
424B3
dk24rs
6 Jun 23
Prospectus supplement
4:05pm
10-Q
bsg4mk xdp
12 May 23
Quarterly report
9:23pm
10-K
tfm72kg
14 Apr 23
Annual report
4:22pm